Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
AstraZeneca
Moodys
Mallinckrodt
Colorcon

Last Updated: May 28, 2022

CLINICAL TRIALS PROFILE FOR DICLOFENAC SODIUM


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Diclofenac Sodium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00092378 ↗ A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2003-09-01 This purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following bunionectomy surgery.
NCT00092703 ↗ Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2002-06-27 The purpose of this study is to compare the gastrointestinal tolerability of an investigational drug to an approved drug in the treatment of osteoarthritis during one year treatment period.
NCT00092742 ↗ Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072) Completed Merck Sharp & Dohme Corp. Phase 3 2003-02-01 The purpose of this study is to evaluate the long-term safety of an investigational drug versus an approved drug for the relief of pain in patients with rheumatoid arthritis.
NCT00140972 ↗ A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 4 2004-12-03 A Study to Assess Etoricoxib versus Diclofenac in Chinese Patients with Osteoarthritis of the Knee or Hip
NCT00171626 ↗ Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis Completed Novartis Phase 3 2004-08-01 This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of knee osteoarthritis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Diclofenac Sodium

Condition Name

Condition Name for Diclofenac Sodium
Intervention Trials
Pain 13
Osteoarthritis 11
Healthy 7
Postoperative Pain 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Diclofenac Sodium
Intervention Trials
Osteoarthritis 21
Osteoarthritis, Knee 14
Pain, Postoperative 9
Sprains and Strains 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Diclofenac Sodium

Trials by Country

Trials by Country for Diclofenac Sodium
Location Trials
United States 204
India 31
Brazil 13
Egypt 12
China 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Diclofenac Sodium
Location Trials
Florida 16
Texas 14
California 11
Pennsylvania 9
Ohio 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Diclofenac Sodium

Clinical Trial Phase

Clinical Trial Phase for Diclofenac Sodium
Clinical Trial Phase Trials
Phase 4 32
Phase 3 41
Phase 2/Phase 3 4
[disabled in preview] 31
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Diclofenac Sodium
Clinical Trial Phase Trials
Completed 94
Unknown status 19
Recruiting 11
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Diclofenac Sodium

Sponsor Name

Sponsor Name for Diclofenac Sodium
Sponsor Trials
Novartis 12
Merck Sharp & Dohme Corp. 6
Javelin Pharmaceuticals 5
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Diclofenac Sodium
Sponsor Trials
Other 84
Industry 82
NIH 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson
McKesson
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.